A key trend shaping the Cell Lysis And Fractionation Market involves the Increasing Focus On Introducing Viral Vector Lysis Kit For Enhanced Cell Lysis And Fractionation Solutions
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Cell Lysis And Fractionation Market During 2026–2030?
The cell lysis and fractionation market size has shown significant expansion in recent years. This market is expected to increase from $3.69 billion in 2025 to $3.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has been driven by factors such as escalating molecular biology research activity, the expansion of proteomics studies, an increase in the application of nucleic acid purification techniques, the growth of life science laboratories, and a greater demand for standardized sample preparation methods.
The cell lysis and fractionation market size is projected to experience robust expansion over the coming years, reaching $5.16 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.9%. This anticipated growth stems from factors such as increased investments in proteomics and genomics research, a growing embrace of automated sample preparation, a heightened emphasis on high-throughput analysis, the expansion of biopharmaceutical research pipelines, and the rising deployment of integrated laboratory systems. Key trends foreseen during this period encompass the wider adoption of automated cell lysis systems, a surging demand for highly efficient protein extraction, an increased application of chemical and mechanical lysis techniques, the broadening scope of fractionation-based sample preparation, and an intensified focus on maintaining sample integrity.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp
Which Economic Or Industry Drivers Are Impacting The Cell Lysis And Fractionation Market?
The increasing emphasis on personalized medicine is anticipated to stimulate growth in the cell lysis and fractionation markets in the coming period. Personalized medicine represents a nascent medical approach that utilizes an individual’s genetic profile to diagnose and treat illnesses, customizing medical choices and therapies according to each patient’s distinct genetic composition. Cell lysis and fractionation are fundamental to precision medicine, enabling the isolation and examination of specific subcellular components, such as proteins, organelles, and nucleic acids, from patient samples. This capability empowers scientists and medical practitioners to investigate the molecular mechanisms of disease and formulate bespoke treatments tailored to each patient’s unique molecular characteristics. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that in 2023, the Food and Drug Administration (FDA) approved 7 new personalized treatments for cancer, from a total of 26 personalized treatments, which was a notable rise from the 12 approved in 2022. Consequently, the expanding focus on personalized medicine is propelling the development of the cell lysis and fractionation markets.
How Are The Various Segments Of The Cell Lysis And Fractionation Market Categorized?
The cell lysis and fractionation market covered in this report is segmented –
1) By Type: Mammalian Cells, Microbial Cells
2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation
3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies
Subsegments:
1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines
2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells
Which Trends Are Impacting The Growth Of The Cell Lysis And Fractionation Market?
Leading firms within the cell lysis and fractionation market are concentrating on introducing sophisticated solutions, including CGT (cell and gene therapy) viral vector lysis kits, to secure a competitive advantage. These kits provide an easier AAV (Adeno-associated virus) lysis approach designed to enhance SOPs (Standard Operating Procedures), quality control, and safety, concurrently standardizing bioprocessing workflows. As an illustration, in July 2023, QIAGEN, a Germany-based company specializing in sample and assay technologies, unveiled its new CGT Viral Vector Lysis Kit, enabling the quantification of virus titers for various serotypes through a precise and consistent method beginning with cell lysates. This new CGT viral vector lysis kit augments QIAGEN’s quickly growing digital PCR product line for the biopharma sector, which currently features three QIAcuity Residual DNA Quantification Kits for assessing host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays used in adeno-associated virus (AAV) titer quantification.
Which Major Firms Influence Developments In The Cell Lysis And Fractionation Market?
Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.
Read the full cell lysis and fractionation market report here:
https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report
What Are The Top-Performing Regions Within The Cell Lysis And Fractionation Market?
North America was the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cell Lysis And Fractionation Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp
Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2026, By The Business Research Company
Cell Separation Technologies Global Market Report
https://www.thebusinessresearchcompany.com/report/cell-separation-technologies-global-market-report
Cell Therapy Technologies Global Market Report
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Cell Harvesting Global Market Report
https://www.thebusinessresearchcompany.com/report/cell-harvesting-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
